Discussion
Amifampridine, the active ingredient in Firdapse, provides clinical benefits for people with Lambert-Eaton myasthenic syndrome (LEMS), while use of immunosuppressive treatments increases over the disease course, according to a single-center study spanning more than 30 years in the Netherlands. In addition, about one in four patients had begun…